PABLO RÍOS MARCO-rekin lankidetzan egindako argitalpenak (2)

2022

  1. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors

    Pharmaceutics, Vol. 13, Núm. 9